Single Fluoroscopy Versus Transesophageal Echocardiogram: A Comparative Evaluation for Left Atrial Appendage Occlusion With LACbes Device

Mingfei Li, Dawei Lin, Lei Zhang, Jianing Fan, Wenzhi Pan, Xiaochun Zhang, Daxin Zhou, Junbo GeCardiovascular 2025 · DOI

TL;DR

This study investigates whether fluoroscopy alone can safely and effectively guide Left Atrial Appendage Occlusion (LAAO) procedures using the LACbes device, comparing it to the standard approach using both fluoroscopy and transesophageal echocardiography (TEE). The findings suggest that fluoroscopy-only guidance is a promising, cost-effective, and more efficient alternative, leading to shorter procedure times and hospital stays without compromising safety or efficacy.

What Problem Does This Paper Address?

For patients with nonvalvular atrial fibrillation (AF) at high risk of stroke, Left Atrial Appendage Occlusion (LAAO) is a viable alternative to long-term oral anticoagulation. Traditionally, LAAO procedures are performed under general anesthesia (GA) with guidance from both X-ray fluoroscopy and transesophageal echocardiography (TEE). While effective, this approach has drawbacks: GA increases risks for patients with comorbidities, elevates costs, and prolongs hospital stays. TEE also carries its own risks, such as throat injuries. Recent advancements have explored using fluoroscopy alone for LAAO with certain devices, eliminating the need for GA and TEE. However, the feasibility and safety of this minimalist approach using the newer LACbes device remained unexplored. This paper addresses this gap by evaluating the efficacy and safety of LAAO with the LACbes device guided solely by fluoroscopy.

Methods

The study involved a retrospective analysis of 240 patients who underwent LAAO with the LACbes device using both TEE and fluoroscopy under general anesthesia. This was compared to a prospective cohort of 237 patients who underwent the same procedure using only fluoroscopy under local anesthesia.

Key methodological aspects include:

  • Device: The LACbes device, a dual-seal LAA occluder with a disc-lobe configuration and isogenous barbs for enhanced safety.
  • Guidance Techniques:
    • Retrospective Cohort: General anesthesia, TEE for visualization and measurements (LAA inner diameter, landing zone, depth), and fluoroscopy for overall guidance. Device positioning, anchoring, compression, and peridevice leak (PDL) were assessed using both modalities.
  • Prospective Cohort: Local anesthesia, fluoroscopy for overall guidance, and transthoracic echocardiogram (TTE) for transseptal puncture confirmation and ruling out pericardial effusion. Intraprocedural angiography at specific angles (RAO30°+ CAU 20°-30°/CRA 20°-30° and AP+CAU10°-20°) was used for LAA ostium measurement and device size selection. Device deployment and functionality were evaluated against PAST criteria (proper position, absolute anchor, separate seal, typical tire).
  • Endpoints: Clinical study endpoints included successful LAA closure (absence or minor residual shunt ≤ 3 mm), primary and secondary adverse events (death, systemic embolism, ischemic stroke, pericardial effusion, etc.), and peridevice leak (PDL) severity.
  • Follow-up: Patients were monitored overnight and discharged the next day if no major complications occurred. Anticoagulation was recommended for 2 months, followed by dual antiplatelet therapy for up to 6 months. Clinical follow-up (TEE) at 3 months and telephone visits every 3 months for up to 2 years were conducted.
  • Statistical Analysis: Standard statistical methods were used, including t-tests, Mann-Whitney U tests, chi-square tests, Fisher's exact tests, and Kaplan-Meier survival analysis.

Datasets

Not discussed in the paper. The study utilized patient data from procedures performed at Zhongshan Hospital, Fudan University.

Key Insights and Ideas

  • Fluoroscopy-Only is Viable: The study strongly suggests that fluoroscopy alone is a safe and effective method for guiding LAAO with the LACbes device, challenging the necessity of TEE in all cases.
  • Efficiency Gains: The fluoroscopy-only approach leads to significant reductions in procedure time, hospital stay, and associated costs, making it a more patient-friendly and economically attractive option.
  • Comparable Safety and Efficacy: Despite the reduced imaging modalities, the fluoroscopy-only group demonstrated comparable rates of implantation success, periprocedural complications, and long-term adverse events (including PDL and device thrombus) to the TEE-guided group.
  • Strategic Angiography: The paper highlights the importance of a specific angiography strategy (using cranial, tangential, and working positions) for accurate LAA assessment and device deployment when relying solely on fluoroscopy.
  • Operator Expertise Matters: The authors acknowledge that the success of fluoroscopy-only guidance is dependent on the expertise of the operators and the volume of procedures performed at a center.

Key Results

  • Implantation Success: The implantation success rate was high in both groups: 99.2% in the retrospective (TEE + fluoroscopy) cohort and 98.7% in the prospective (fluoroscopy-only) cohort, with no statistically significant difference.
  • Procedure Time: The prospective (fluoroscopy-only) group had significantly shorter overall operation times (45.6 ± 7.8 min) compared to the retrospective group (55.5 ± 7.2 min, p < 0.001).
  • Fluoroscopy Time: Conversely, fluoroscopy time was longer in the prospective group (11.3 ± 1.7 min) than in the retrospective group (9.3 ± 2.0 min, p < 0.001), which is expected given its sole reliance on this modality.
  • Hospital Stay and Costs: Patients in the prospective group had shorter hospital stays (3.1 ± 0.5 days vs. 4.5 ± 0.7 days, p < 0.001) and incurred significantly lower hospitalization costs ($11,825.2 ± $768.2 vs. $13,189.5 ± $915.3, p < 0.001).
  • Complications: No statistically significant differences were observed in periprocedural complications (cardiac tamponade, stroke, device embolization, etc.) or long-term adverse events (death, cardiac death, stroke, device dislocation, PDL, device thrombus) between the two cohorts. Mild PDL rates were slightly higher in the fluoroscopy-only group (8.4% vs. 6.3%), but this difference was not statistically significant.
  • Survival: Kaplan-Meier survival analysis showed no significant difference in cumulative survival between the two groups over a median 2-year follow-up (p = 0.83).

Limitations and Future Work

Limitations:

  • Single-Center Study: The research was conducted at a single medical center, which may limit the generalizability of the findings due to potential variations in patient populations and procedural practices.
  • Sample Size: The sample size, while substantial, might be considered limited for detecting rare adverse events, and further analysis of prognostic factors for outcomes like PDL is warranted.
  • Operator Expertise: The success of the fluoroscopy-only approach is heavily reliant on the expertise of experienced operators. This may pose a challenge for less experienced teams.

Future Work:

  • Further research is needed to fully understand the safety profile and effectiveness of the LACbes device in clinical practice, particularly with fluoroscopy-only guidance.
  • The authors suggest that for centers with experienced operators and high LAAO volumes, this minimalist approach could be considered for patients with contraindications to GA and/or TEE.
  • Additional analysis of prognostic factors for adverse events like PDL would provide deeper insights.

Summary updated

Abstract

The use of fluoroscopy as the sole guidance modality for LAAO with the LACbes device demonstrated promising results in terms of efficacy and safety. It emerges as a viable and cost-effective alternative, offering a more efficient approach for LAAO.
BibTeX
@inproceedings{li2025single,
  author = {Mingfei Li and Dawei Lin and Lei Zhang and Jianing Fan and Wenzhi Pan and Xiaochun Zhang and Daxin Zhou and Junbo Ge},
  title = {{Single Fluoroscopy Versus Transesophageal Echocardiogram: A Comparative Evaluation for Left Atrial Appendage Occlusion With LACbes Device}},
  booktitle = {Cardiovascular},
  year = {2025},
  doi = {10.1155/cdr/9933780},
}
Figure